PUBLICATION

Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.


PUBLICATION ARCHIVES

SEARCH THE ARCHIVES

Issue #3, March 2002

Spending on Direct-to-Consumer Drug Advertising Up $1.7 Billion; Remains Secondary to Other Marketing Strategies


Bad Press: How Do Lawyers Defend High Profile Drug Recall Cases?


The Warnings Page: New Advisories Issued On Paxil, Lotronex, Zyban, and Herbal Supplement SPES/PC SPES


Pharmaceutical Litigation and Permanent Partnership


Mississippi Judge Halves $100 Million Propulsid Verdict

The Mississippi judge who presided over the first trial of personal injury claims filed on behalf of those who used the recalled heartburn drug Propulsid has cut the $100 million verdict in half


Fifth Circuit Rules Duract Plaintiffs Have No Standing Absent Injury

A federal circuit court in Texas has ruled that plaintiffs in a breach of warranty lawsuit seeking economic damages against Wyeth-Ayerst Laboratories have no standing to bring suit, because they did not suffer injury


Plaintiffs Failed to Show Zoloft Misrepresentation Caused Boy's Suicide, Kansas Judge Rules

Plaintiffs claiming that defendant Pfizer's alleged misrepresentation of the antidepressant Zoloft caused or contributed to their 13-year-old son's suicide have not shown general or proximate causation


Lamisil's Liver Toxicity Warnings Were Adequate, Fifth Circuit Rules

The plaintiff had developed cholestatic hepatitis after beginning a 12-week course of Lamisil, which his dermatologist prescribed for the treatment of his chronic toenail fungus infection


Court Rules Joinder of Metabolife Distributors Not Fraudulent

A federal district court has ruled that two independent distributors of Metabolife named in a product liability suit were not fraudulently joined


Bayer Denies Allegations in Class Action, Asserts Class Certification Is Improper

Drugmaker Bayer Corp. has filed its answer to a plaintiff's class action complaint denying all allegations and asserting, among others, an affirmative defense that no common questions


Past Issues:


VERDICTRACK

The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.

  • DEFENDANT
  • DISEASE / INJURY
  • PRODUCT
  • PUBLICATION
  • STATE
  • SEARCH BY EXPERT
True